RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Nanoform Finland Oyj Stock

Nanoform Finland Oyj ROCE 2024

Nanoform Finland Oyj ROCE

-0.34

Ticker

NANOFH.HE

ISIN

FI4000330972

WKN

A2P5N7

In 2024, Nanoform Finland Oyj's return on capital employed (ROCE) was -0.34, a 36.76% increase from the -0.25 ROCE in the previous year.

Nanoform Finland Oyj Aktienanalyse

What does Nanoform Finland Oyj do?

Nanoform Finland Plc is a Finnish company operating in the pharmaceutical industry. The company was founded in 2015 and is headquartered in Helsinki. Nanoform's business model is to increase the bioavailability of drugs. Bioavailability refers to the amount of a drug that is actually absorbed by the body. Drug development is a time-consuming and costly process. However, many drugs do not provide sufficient effectiveness due to their poor bioavailability. Nanoform has developed a technology that can improve the bioavailability of drugs. The technology is called "CSP Technology" (Cryo-Spray-Particle-Technology). This is a process in which drugs are broken down into tiny particles and then frozen. Through this process, the particles can be better absorbed by body cells and thus effectively release their effects. The company is divided into different divisions, each targeting specific areas of the pharmaceutical industry. One division is specialized in the development of generics, which are imitation products of existing drugs. Another division focuses on the production of active ingredients for new drugs that are not yet available. Nanoform is also capable of improving already approved drugs through the application of CSP technology. The company works closely with its customers to develop tailored solutions for their specific drugs. This includes comprehensive consulting, analysis of the drug, and the creation of special particles that are customized to the customer's needs. Nanoform's products are known for their high quality and effectiveness in treating diseases. Customers worldwide rely on the company to make their drugs more effective and achieve better results for their patients. Nanoform continuously works on the further development and improvement of its technology and products. The company invests heavily in research and development of new solutions for the pharmaceutical industry. Currently, the company is also planning to expand into the Asian market. Nanoform is an innovative company that shapes the future of the pharmaceutical industry. Through its innovative CSP technology and industry know-how, Nanoform achieves a new dimension in the production of medicines and thus enhances their effectiveness. Nanoform Finland Oyj ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Nanoform Finland Oyj's Return on Capital Employed (ROCE)

Nanoform Finland Oyj's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Nanoform Finland Oyj's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Nanoform Finland Oyj's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Nanoform Finland Oyj’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Nanoform Finland Oyj stock

What is the ROCE (Return on Capital Employed) of Nanoform Finland Oyj this year?

The ROCE of Nanoform Finland Oyj is -0.34 undefined this year.

How has the ROCE (Return on Capital Employed) of Nanoform Finland Oyj developed compared to the previous year?

The ROCE of Nanoform Finland Oyj has increased by 36.76% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Nanoform Finland Oyj?

A high Return on Capital Employed (ROCE) indicates that Nanoform Finland Oyj has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Nanoform Finland Oyj?

A low ROCE (Return on Capital Employed) can indicate that Nanoform Finland Oyj has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Nanoform Finland Oyj impact the company?

An increase in the ROCE of Nanoform Finland Oyj can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Nanoform Finland Oyj affect the company?

A decrease in ROCE of Nanoform Finland Oyj can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Nanoform Finland Oyj?

Some factors that can affect Nanoform Finland Oyj's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Nanoform Finland Oyj so important for investors?

The ROCE of Nanoform Finland Oyj is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Nanoform Finland Oyj take to improve the ROCE?

To improve the ROCE, Nanoform Finland Oyj can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Nanoform Finland Oyj pay?

Over the past 12 months, Nanoform Finland Oyj paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nanoform Finland Oyj is expected to pay a dividend of 0 EUR.

What is the dividend yield of Nanoform Finland Oyj?

The current dividend yield of Nanoform Finland Oyj is .

When does Nanoform Finland Oyj pay dividends?

Nanoform Finland Oyj pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Nanoform Finland Oyj?

Nanoform Finland Oyj paid dividends every year for the past 0 years.

What is the dividend of Nanoform Finland Oyj?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Nanoform Finland Oyj located?

Nanoform Finland Oyj is assigned to the 'Health' sector.

Wann musste ich die Aktien von Nanoform Finland Oyj kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nanoform Finland Oyj from 9/29/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Nanoform Finland Oyj pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Nanoform Finland Oyj in the year 2023?

In the year 2023, Nanoform Finland Oyj distributed 0 EUR as dividends.

In which currency does Nanoform Finland Oyj pay out the dividend?

The dividends of Nanoform Finland Oyj are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Nanoform Finland Oyj

Our stock analysis for Nanoform Finland Oyj Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nanoform Finland Oyj Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.